Humana Q2 Profit Climbs, Cuts FY26 EPS Outlook, Backs Adj. Earnings, Revenue View; Stock Downrttnews·1 day ago, 05:47 AMHUM-5.99%
Pre-market hot trades in US stocks: Humana falls 8.67% in pre-market, despite earnings exceeding expectations and analysts raising target prices, the stock price still declinesPrice Alert·1 day ago, 05:07 AMHUM-5.99%
Humana Tops Q2 Earnings Expectations but Lowers Profit Forecast Amid Medicare Advantage ShiftsStock Invest·23 hours agoHUM-5.99%
Humana FY26 Q2 net income rises 27.6% to $693 million; revenue climbs 26.2% to $40.87 billionPUBT·16 hours agoHUM-5.99%
UnitedHealth Group Incorporated (NYSE:UNH) Given Consensus Recommendation of "Moderate Buy" by AnalystsMarket Beat·4 hours agoUNH-1.92%UNHG-3.97%
How Mixed Q2 Earnings and Higher EPS Guidance Will Impact Elevance Health (ELV) InvestorsSimplywall·1 day ago, 06:21 PMELV-2.53%
Humana Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analystsbenzinga_article·1 day ago, 01:44 AMHUM-5.99%
Could CVS’s Smaller Pharmacies And Nutrition Partnerships Subtly Reshape Its Long‑Term Investment Story (CVS)?Simplywall·1 day ago, 02:20 PMCVS-3.13%
Elevance Health, Inc. $ELV Shares Acquired by Cetera Investment AdvisersMarket Beat·Jul 27 at 02:44 AMELV-2.53%